Both in Pharmaceuticals
Abbott Laboratories vs Vertex Pharmaceuticals
Over the past year ABT returned −14.1% and VRTX returned +31.3%; their daily moves had a correlation of 0.20.
ABT −14.1% VRTX +31.3%Growth of $1, one year, split-adjusted
| Metric | ABT | VRTX |
|---|---|---|
| Price | $106.20 | $558.88 |
| Market cap | $183.77B | $141.65B |
| Today | +1.56% | +3.50% |
| 1 month | +9.8% | +10.3% |
| 6 months | +18.7% | +31.8% |
| Year to date | −15.2% | +23.3% |
| 1 year | −14.7% | +34.0% |
| Revenue growth (YoY) | +13.0% | +12.5% |
| Gross margin | 57.7% | 85.3% |
| Net margin | 7.4% | 33.0% |
| P/E (TTM) | 33.9× | 32.2× |
| Price / sales | 3.9× | 11.3× |
| Net cash | -$27.00B | $7.85B |
| Dividend yield | 2.37% | — |
| Volatility (60d) | 21.3% | 28.7% |
| Short % of float | 1.0% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).